Affinity Investment Advisors’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
SCM
Affinity Investment Advisors's HALO Position: Q1 2024 in Review
Affinity Investment Advisors sold out of Halozyme (HALO) in Q1 2024, closing a stake of 8,886 shares — an estimated $328K sold.
Affinity Investment Advisors first reported a position in HALO in Q3 2021 and held it in 10 quarters. The position peaked at $1.09M in Q4 2022. 414 funds tracked by Wall St. Rank hold HALO as of Q1 2024.
- Affinity Investment Advisors reported no remaining Halozyme position as of Q1 2024 after selling out during the quarter.
- Affinity Investment Advisors sold 8,886 Halozyme shares in Q1 2024, an estimated $328K.
- Affinity Investment Advisors first reported a position in Halozyme in Q3 2021 and held it in 10 quarters.
- Affinity Investment Advisors's Halozyme position peaked at $1.09M in Q4 2022.
- 414 funds tracked by Wall St. Rank held Halozyme as of Q1 2024.
Based on Affinity Investment Advisors's 13F filing for Q1 2024, filed 3 May 2024.